A 3-Week Inpatient Rehabilitation Programme Improves Body Composition in People with Cystic Fibrosis with and Without Elexacaftor/Tezacaftor/Ivacaftor Therapy.

Nutrients · 2025 · PMC12348923 · PMID 40806025

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

This aspect appears to be highly significant given that, in April 2025, the European Medicines Agency decided to extend the indication for ETI therapy to all pwCF who have at least one non-Class I mutation in the CFTR gene [ 10 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.